Articles with public access mandates - David AllandLearn more
Available somewhere: 119
Rapid molecular detection of tuberculosis and rifampin resistance
CC Boehme, P Nabeta, D Hillemann, MP Nicol, S Shenai, F Krapp, ...
New England Journal of Medicine 363 (11), 1005-1015, 2010
Mandates: US National Institutes of Health
Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
D Helb, M Jones, E Story, C Boehme, E Wallace, K Ho, JA Kop, ...
Journal of clinical microbiology 48 (1), 229-237, 2010
Mandates: US National Institutes of Health
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
SE Dorman, SG Schumacher, D Alland, P Nabeta, DT Armstrong, B King, ...
The Lancet infectious diseases 18 (1), 76-84, 2018
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health …
Evaluation of the analytical performance of the Xpert MTB/RIF assay
R Blakemore, E Story, D Helb, JA Kop, P Banada, MR Owens, ...
Journal of clinical microbiology 48 (7), 2495-2501, 2010
Mandates: US National Institutes of Health
Better tests, better care: improved diagnostics for infectious diseases
AM Caliendo, DN Gilbert, CC Ginocchio, KE Hanson, L May, TC Quinn, ...
Clinical Infectious Diseases 57 (suppl_3), S139-S170, 2013
Mandates: US National Institutes of Health
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
S Chakravorty, AM Simmons, M Rowneki, H Parmar, Y Cao, J Ryan, ...
MBio 8 (4), 10.1128/mbio. 00812-17, 2017
Mandates: US National Institutes of Health
SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis
K Tahlan, R Wilson, DB Kastrinsky, K Arora, V Nair, E Fischer, SW Barnes, ...
Antimicrobial agents and chemotherapy 56 (4), 1797-1809, 2012
Mandates: US National Institutes of Health
Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?
V Vadwai, C Boehme, P Nabeta, A Shetty, D Alland, C Rodrigues
Journal of clinical microbiology 49 (7), 2540-2545, 2011
Mandates: US National Institutes of Health
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
Mandates: Bill & Melinda Gates Foundation, European Commission, Government of Spain …
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
AL Manson, KA Cohen, T Abeel, CA Desjardins, DT Armstrong, ...
Nature genetics 49 (3), 395-402, 2017
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
ST Malherbe, S Shenai, K Ronacher, AG Loxton, G Dolganov, M Kriel, ...
Nature medicine 22 (10), 1094-1100, 2016
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway …
H Safi, S Lingaraju, A Amin, S Kim, M Jones, M Holmes, M McNeil, ...
Nature genetics 45 (10), 1190-1197, 2013
Mandates: US National Institutes of Health
Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings
PP Banada, SK Sivasubramani, R Blakemore, C Boehme, MD Perkins, ...
Journal of clinical microbiology 48 (10), 3551-3557, 2010
Mandates: US National Institutes of Health
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
C Vilchèze, Y Av‐Gay, R Attarian, Z Liu, MH Hazbón, R Colangeli, B Chen, ...
Molecular microbiology 69 (5), 1316-1329, 2008
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Multicenter evaluation of the cepheid Xpert Xpress SARS-CoV-2 test
MJ Loeffelholz, D Alland, SM Butler-Wu, U Pandey, CF Perno, A Nava, ...
Journal of clinical microbiology 58 (8), 10.1128/jcm. 00926-20, 2020
Mandates: US National Institutes of Health
Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and Rifampin
H Safi, B Sayers, MH Hazbón, D Alland
Antimicrobial agents and chemotherapy 52 (6), 2027-2034, 2008
Mandates: US National Institutes of Health
Host blood RNA signatures predict the outcome of tuberculosis treatment
EG Thompson, Y Du, ST Malherbe, S Shankar, J Braun, J Valvo, ...
Tuberculosis 107, 48-58, 2017
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Evaluation of a rapid molecular drug-susceptibility test for tuberculosis
YL Xie, S Chakravorty, DT Armstrong, SL Hall, LE Via, T Song, X Yuan, ...
New England Journal of Medicine 377 (11), 1043-1054, 2017
Mandates: US National Institutes of Health
The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates
R Colangeli, A Haq, VL Arcus, E Summers, RS Magliozzo, A McBride, ...
Proceedings of the National Academy of Sciences 106 (11), 4414-4418, 2009
Mandates: US National Institutes of Health
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
R Wilson, P Kumar, V Parashar, C Vilchèze, R Veyron-Churlet, ...
Nature chemical biology 9 (8), 499-506, 2013
Mandates: US National Institutes of Health, Wellcome Trust
Publication and funding information is determined automatically by a computer program